歌礼药业（浙江）有限公司

Country

Ownership: -

Established: 2014-09-24

Employees: -

Market Cap: -

Website: https://www.ascletis.com

Clinical Trials

0

Active:0

Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Danoprevir Sodium Tablets

Product Name: 戈诺卫

Approval Number: 国药准字H20180008

Approval Date: Jan 18, 2023

NMPA

Ritonavir Tablets

Product Name: 利托那韦片

Approval Number: 国药准字H20213698

Approval Date: Sep 7, 2021

NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.